<scp>NMDA</scp> antagonists use in bipolar depression: A case report

Dr. El-Mallakh is a speaker for Axsome, Intracellular, Janssen, Lundbeck, Noven, Otsuka, and Vanda. None of the other authors have potential conflicts of interest. Data regarding this case presentation are not available.

Authors

Institutions

Publication Details

Journal
Bipolar Disorders
Published
2024-09-01
DOI
https://doi.org/10.1111/bdi.13496
Citations
1
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NMDA antagonists use in bipolar depression: A case report

Rif S. El‐Mallakh, Sara Abell, Kirolos Ibrahim
1 citations
Bipolar Disorders
Treatment of Major Depression
0.45
article

NMDA antagonists use in bipolar depression: A case report

Rif S. El‐Mallakh, Sara Abell, Kirolos Ibrahim
article en
1 citations

Abstract

Dr. El-Mallakh is a speaker for Axsome, Intracellular, Janssen, Lundbeck, Noven, Otsuka, and Vanda. None of the other authors have potential conflicts of interest. Data regarding this case presentation are not available.

Bipolar DisordersVol. 27(1)
University of Louisville (US)
Openalex Percentile: Top 32%
Treatment of Major Depression
0.45
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<scp>NMDA</scp> antagonists use in bipolar depression: A case report — Rif S. El‐Mallakh, Sara Abell, et al. · Bipolar Disorders (2024) | TGRS Research Map | TGRS